Spora Health, Inc.

Spora Health, Inc. is a healthcare technology company focused on improving health outcomes through innovative digital solutions tailored to underserved communities. Founded in 2020 and headquartered in San Francisco, US, Spora Health, Inc. provides healthcare solutions aimed at enhancing accessibility and effectiveness.

The company was formed by founders Dan Miller and Frederic Puig. Spora Health raised USD 3. 00 mn in Seed funding on March 12, 2021, co-led by M13, MaC Venture Capital, and Refactor Capital, alongside returning investors Headwater Ventures, Human Ventures, and Techstars. This funding marks the total amount raised by the company, with two completed deals to date.

Spora Health offers technology-driven healthcare solutions designed to enhance operational efficiency and improve user experiences. Their products address critical needs in healthcare, particularly for underserved populations. These solutions are marketed in North America, Europe, and select regions in Asia, catering to various sectors, including health and wellness. The company utilizes a subscription-based revenue model where clients pay periodic fees for access to its healthcare solutions.

This model supports a steady income stream and allows for scalability in service offerings. Different pricing tiers are available based on features and user limits, ensuring that businesses can choose plans that align with their operational needs. Strategic partnerships further enhance the service value delivered to clients. Following its Seed funding round on March 12, 2021, Spora Health, Inc.

plans to use the USD 3. 00 mn to boost hiring, product development, and marketing initiatives. The company aims to expand its presence across the US market, targeting new geographic regions. Upcoming product launches are being developed to meet the needs of its client base, although specific release dates are not disclosed.